I am not swinging this one, even though it is tempting. I recently sold NVAX at 15% profit, and due to strong correlation with MRNA I was considering selling my MRNA as well, in which case I would have made 14% right now. However, I decided to hold because of 2 reasons : 1) AstraZeneca just took a major hit (if you don't know about it, catch up on the news)....
PLEASE READ THE ENTIRE POST, IT MIGHT JUST SAVE YOU A SOUR INVESTMENT I have been following MRNA for about a month now, and something interesting has happened that not many people know about. On 4 September, news came out that the CMO, the President AND the CEO have sold large if not all of their holdings.* Now the company says that this is no reason to panic....
Moderna (MRNA) is developing a COVID-19 vaccine candidate that is widely considered one of the frontrunners to bring a vaccine to market; it was the first company to share data about how its experimental vaccine performed in a Phase 1 clinical trial. It has so far soared more than 350% since the start of the year. The main reason is that there has been tremendous...
Nothing too serious here, just an observer on this one. One of my biggest regrets, I pumped money into INO instead of MRNA when they were both cheap when the smart play was covering the field. Noob move... alas, there's always another stock to chase. Anyway, here's a decent stock architecture for anyone playing this. Basically I'm just hoping it dips super low...
SO Moderna spiked from roughly $19.07 to $28 est. in less than 45 minutes after rumors broke into confirmations ending with headlines as Mordova has officially announced a vaccination for COVID-19 has been developed yet with months of red tape ahead of us (still have yet to undergo animal testing, clinical trials, human testing, then once the vaccination has been...
$MRNA is working on a vaccine for the coronavirus. If the stock breaks out above $36, it should take off. Risk looks to be minimal. The trade should work out right away. Can do buy stop at $36.01 and risk 20 to 50 cents, depending on your risk tolerance. Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger...